Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas

NCT05127096 is registered in ClinicalTrials.gov with CellMax Life as lead sponsor.

NCT NCT05127096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05127096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas
Lead sponsor
CellMax Life
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2020
Completion date
December 30, 2022
Enrollment
1,000 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer screening